Please assess the completion status of the following clinical trial:

Trial Title: Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Males and females (18-75 years of age)~* At least two cardiovascular disease risk factors~* Must have been following a restrictive diet~* Diagnosis of primary hypercholesterolemia or combined dyslipidemia~Exclusion Criteria:~* Homozygous familial hypercholesterolemia~* Conditions which may cause secondary dyslipidemia~* Uncontrolled diabetes mellitus~* Abnormal pancreatic, liver or renal function~* Abnormal serum creatine kinase (CK) above the pre-specified level

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Pitavastatin 4 mg QD (Type: EXPERIMENTAL): Pitavastatin 4 mg once daily
- Simvastatin 40 mg QD (Type: ACTIVE_COMPARATOR): Simvastatin 40 mg once daily

Based on this trial design, predict the completion outcome and termination type (if applicable).